Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Futreal

Showing results (81-90 of 389) with videos related to

Pageof 39
Sort By:
The Journal of Pathology|May 21, 2011
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursM Fernanda Amary, Krisztian Bacsi, Francesca Maggiani, et al.
Leukemia|February 27, 2020
T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloidWei Wang, Hannah Beird, Caleb Jonathan Kroll, et al.
Gut Microbes|September 6, 2024
Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolismSuet-Ying Kwan, Kristyn A Gonzales, Mohamed A Jamal, et al.
Frontiers in Oncology|April 9, 2024
Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma featuresHui Li, Xin Hu, Matthew S Ning, et al.
Nature Communications|June 29, 2018
KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovaryR Tyler Hillman, Joseph Celestino, Christopher Terranova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumorsTimothy A Yap, Laura Vidal, Jan Adam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatmentDaniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Leukemia & Lymphoma|February 19, 2026
Ten-year long-term survivors of blastic plasmacytoid dendritic cell neoplasm (BPDCN)Amritpal Singh, Naval Daver, Sanam Loghavi, et al.
Cell|September 27, 2016
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyJianjun Gao, Lewis Zhichang Shi, Hao Zhao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2018
High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic CancerSarah A Bannon, Maria F Montiel, Jennifer B Goldstein, et al.
Pageof 39

Showing results (81-90 of 389) with videos related to

Sort By:
Pageof 39
The Journal of Pathology|May 21, 2011
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursM Fernanda Amary, Krisztian Bacsi, Francesca Maggiani, et al.
Leukemia|February 27, 2020
T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloidWei Wang, Hannah Beird, Caleb Jonathan Kroll, et al.
Gut Microbes|September 6, 2024
Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolismSuet-Ying Kwan, Kristyn A Gonzales, Mohamed A Jamal, et al.
Frontiers in Oncology|April 9, 2024
Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma featuresHui Li, Xin Hu, Matthew S Ning, et al.
Nature Communications|June 29, 2018
KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovaryR Tyler Hillman, Joseph Celestino, Christopher Terranova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumorsTimothy A Yap, Laura Vidal, Jan Adam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatmentDaniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Leukemia & Lymphoma|February 19, 2026
Ten-year long-term survivors of blastic plasmacytoid dendritic cell neoplasm (BPDCN)Amritpal Singh, Naval Daver, Sanam Loghavi, et al.
Cell|September 27, 2016
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyJianjun Gao, Lewis Zhichang Shi, Hao Zhao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2018
High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic CancerSarah A Bannon, Maria F Montiel, Jennifer B Goldstein, et al.
Pageof 39